title: Role of lithium carbonate in pancytopenia following cytotoxic therapy.
abstract: Twenty-four patients presenting with pancytopenia following cytotoxic therapy were studied. Seventeen of them were given 900 mg/day of lithium carbonate apart from other supportive measures. Seven patients were used as controls and were not given any lithium. After 2 weeks, granulocyte count was significantly higher (p less than .05) in lithium-treated group. Platelet count was also higher though not statistically significant.
authors.forename: S N
authors.initials: SN
authors.lastname: Agarwal
authors.forename: B
authors.initials: B
authors.lastname: Chatterjee
authors.forename: B N
authors.initials: BN
authors.lastname: Tripathi
authors.forename: R
authors.initials: R
authors.lastname: Chandra
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010198:Pancytopenia / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D008094:Lithium